Prednisolone Acetate
Brand names: Pred Forte, Pred Mild, Prednisolone Acetate
At a glance
- Medicare prescriptions, 2024
- 3,590,185
- Medicare drug cost
- $145.2M
- Average cost per prescription
- $40.44
- Clinicians who prescribed it
- 28,562
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
PRED FORTE ® is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.
From the FDA-approved prescribing information (label dated February 2024). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Ophthalmology 81.7%
- Optometrists 11.3%
- Retina Specialist 4.7%
- Internal Medicine 0.6%
- Nurse Practitioners 0.4%
- Family Medicine 0.4%
- Physician Assistants 0.2%
- ENT (Otolaryngology) 0.2%
- Geriatric Medicine 0.1%
- General Practice 0.1%
- Hospitalist 0.0%
- Plastic Surgery 0.0%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions rose 34% from 2019 to 2024.
Biggest change by state since 2019
- Delaware +79%
- Oklahoma +63%
- Connecticut +62%
- Louisiana +56%
- Tennessee +54%
- Nevada (smallest change) +10%
- New Hampshire (smallest change) +16%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
3 recalls since 2020
- Jun 2026 · Lupin Pharmaceuticals Inc. · Class II
Presence of Foreign Substance - May 2026 · AbbVie Inc. · Class III
Failed Stability Specifications - Apr 2022 · McKesson Medical-Surgical Inc. Corporate Office · Class II
cGMP deviations: Temperature abuse
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.